Manufacturing roundup: Alcami acquired by capital groups; Wheeler Bio starts on new manufacturing site in Oklahoma
Two investment groups have come together to purchase the CDMO Alcami.
Global Healthcare Opportunities, otherwise known as GHO Capital, and The Vistra Group joined to acquire a controlling interest in the Alcami Corporation from funds associated with two other investment groups, Ampersand Capital Partners and Madison Dearborn Partners. The financial details of the deal were not disclosed to Endpoints News.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.